Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 10 February 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett's esophagus

The latest issue of Gastroenterology investigates the use of radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett's esophagus and early esophageal adenocarcinoma.

News image

Patients with Barrett's esophagus and high-grade dysplasia or early neoplasia increasingly receive endoscopic mucosal resection and radiofrequency ablation therapy.

Dr Rehan Haidry and colleagues from the United Kingdom analyzed data from a UK registry that follows the outcomes of patients with Barrett's Esophagus who have undergone resection and radiofrequency ablation for neoplasia.

The research team reported that they collected data on 335 patients with Barrett's esophagus and neoplasia, treated at 19 centers in the United Kingdom from 2008 through 2012.

Mean length of Barrett's esophagus segments was 5.8 cm.

Patients' nodules were removed by endoscopic mucosal resection, and the patients then underwent resection and radiofrequency ablation every 3 months until all areas of Barrett's esophagus were ablated or cancer developed.

The research team collected biopsies for 12 months after the first resection and radiofrequency ablation; clearance of high-grade dysplasia, dysplasia, and Barrett's esophagus were assessed

Symptomatic strictures developed in 9% of patients
Gastroenterology

High-grade dysplasia was cleared from 86% of patients, all dysplasia from 81%, and Barrett's esophagus from 62% at the 12-month time point, after a mean of 2.5 resection and radiofrequency ablation procedures.

The doctors noted that complete reversal dysplasia was 15% less likely for every 1-cm increment in Barrett's esophagus length.

Endoscopic mucosal resection before resection and radiofrequency ablation did not provide any benefit.

Invasive cancer developed in 10 patients by the 12-month time point and disease had progressed in 17 patients after a median follow-up time of 19 months.

The doctors found that symptomatic strictures developed in 9% of patients and were treated by endoscopic dilatation.

The team observed that 19 months after therapy began, 94% of patients remained clear of dysplasia.

Dr Haidry's team commented, "We analyzed data from a large series of patients in the United Kingdom who underwent resection and radiofrequency ablation for Barrett's esophagus-related neoplasia and found that by 12 months after treatment, dysplasia was cleared from 81%. "

"Shorter segments of Barrett's esophagus respond better to resection and radiofrequency ablation."

Gastroenterol 2013: 145(1) 87-95
15 July 2013

Go to top of page Email this page Email this page to a colleague

 10 February 2016 
NAFLD in Veterans in the USA
 10 February 2016 
Rectosigmoidoscopy vs colonoscopy in ulcerative colitis
 10 February 2016 
Liver cancer and primary biliary cirrhosis
 09 February 2016 
Cancer-specific prognosis in octogenarians with colorectal cancer
 09 February 2016 
Eosinophilic esophagitis and parental allergies
 09 February 2016 
Bowel preparation for colonoscopy screening
 08 February 2016 
Immunity in the human gut
 08 February 2016 
Cancelled colonoscopy appointments
 08 February 2016 
Cognitive function in Crohn's disease
 05 February 2016 
Helicobacter cinaedi bacteremia
 05 February 2016 
Methotrexate and remission in ulcerative colitis
 05 February 2016 
Treatment for ileal pouch-anal anastomosis for Crohn’s colitis
 04 February 2016 
Diabetes and liver cancer
 04 February 2016 
Colorectal cancer screening
 04 February 2016 
H. pylori and coronary heart disease 
 03 February 2016 
Acute diverticulitis and IBS 
 03 February 2016 
Microbiota of the colonic mucosa and chronic constipation
 03 February 2016 
Guidelines for chronic pancreatitis
 02 February 2016 
Ramosetron and IBS-diarrhea
 02 February 2016 
IBD emergency department visits
 02 February 2016 
Probiotics for H. pylori management
 01 February 2016 
Depressive symptoms in IBD 
 01 February 2016 
Obesity and hepatocellular carcinoma risk
 01 February 2016 
Managing HBV in pregnancy
 29 January 2016 
Colorectal cancer after colonoscopy
 29 January 2016 
Acute diverticulitis in immunosuppressed patients
 29 January 2016 
Vitamin D and colorectal cancer risk
 28 January 2016 
Tissue anti-TNF drug levels and IBD
 28 January 2016 
First line treatment of H. pylori infection
 28 January 2016 
Tetracycline for rosacea increases the risk of IBD
 27 January 2016 
Steroids in children with Crohn's
 27 January 2016 
Self-management IBS program 
 27 January 2016 
Human gut microbiome in IBD 
 26 January 2016 
Smoking and symptomatic diverticular disease
 26 January 2016 
Step-down therapy in PPI-responsive esophageal eosinophilia 
 26 January 2016 
Diet and IBD risk
 25 January 2016 
IBD monitoring using smartphones
 25 January 2016 
Self-management IBS program
 25 January 2016 
Colorectal cancer after a negative screening sigmoidoscopy
 22 January 2016 
Length of Barrett's and cancer
 22 January 2016 
Psychosocial interventions and alcohol abstinence in chronic liver disease
 22 January 2016 
Helicobacter pylori antibiotic resistance
 21 January 2016 
Increasing adenoma detection rate during colonoscope withdrawal
 21 January 2016 
Microscopic colitis current concepts
 21 January 2016 
Statins as a management strategy for constipation 
 20 January 2016 
Health status after bariatric surgery
 20 January 2016 
Hep E infection in West Africa
 20 January 2016 
Preventing endoscopic bacterial transmission
 19 January 2016 
PPIs and phlebotomy in hereditary hemochromatosis
 19 January 2016 
Predicting liver cirrhosis in Hep C
 19 January 2016 
Frozen vs fresh fecal microbiota transplantation
 18 January 2016 
Hospitalization for diverticulitis in the USA
 18 January 2016 
H. pylori and gastric cancer across Europe
 18 January 2016 
Enteral nutrition in children with Crohn's
 15 January 2016 
Alcohol- and HCV-related hepatocellular carcinoma
 15 January 2016 
Recurrent colonic diverticulitis
 15 January 2016 
Colonic diverticula and colorectal cancer risk
 14 January 2016 
Risk stratification of incidentally discovered gallstones
 14 January 2016 
Treatment of refractory cholestatic pruritus
 14 January 2016 
Colonic diverticula and colorectal cancer risk 

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us